TIP-15. Trial in progress: phase IB study of concurrent Azeliragon, a RAGE inhibitor, with craniospinal irradiation in patients with leptomeningeal metastasesK.M. Banson, Jonathan T. Yang, Benjamin T. Cooper et al.|Neuro-Oncology|2025Cited by 0